4DMedical Limited (ASX:4DX – Get Free Report) insider Andreas Fouras bought 1,850,914 shares of 4DMedical stock in a transaction on Friday, January 16th. The shares were purchased at an average cost of A$0.95 per share, with a total value of A$1,760,219.21.
Andreas Fouras also recently made the following trade(s):
- On Wednesday, January 21st, Andreas Fouras sold 263,157 shares of 4DMedical stock. The shares were sold at an average price of A$3.80, for a total value of A$999,996.60.
4DMedical Stock Performance
The company has a debt-to-equity ratio of 7.22, a quick ratio of 6.01 and a current ratio of 1.78.
4DMedical Company Profile
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lungs ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
Featured Articles
- Five stocks we like better than 4DMedical
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for 4DMedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 4DMedical and related companies with MarketBeat.com's FREE daily email newsletter.
